Feras El-Hajji

10PUBLICATIONS
25CO-AUTHORS
Epidemiological modellingMolecular targetsMedical infection agents (incl. prions)Powder and particle technologyHealth policy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 01, 2026
Defining antibiotic use reduction targets for the management of hospital-onset healthcare-associated Clostridioides difficile infection: results of the multi-center TARGET-A project in four UK hospitals.

|Aug 28, 2025
In Vitro and In Vivo Evaluation of Alectinib-Loaded Dendrimer Nanoparticles as a Drug Delivery System for Non-Small Cell Lung Carcinoma.

Mahmood R Atta, Israa Al-Ani, Ibrahim Aldeeb

|Jul 30, 2025
Prevalence, Appropriateness, and Outcomes of Colistin Use in Multidrug-Resistant Pseudomonas aeruginosa Infections: Insights from Hospital Data.

Rana K Abu-Farha, Savana Sobh, Khawla Abu Hammour

|Jun 27, 2024
Evaluation of Solubility, Dissolution Rate, and Oral Bioavailability of β-Cyclodextrin and Hydroxypropyl β-Cyclodextrin as Inclusion Complexes of the Tyrosine Kinase Inhibitor, Alectinib.

Bashar J M Majeed, Mohammed A Saadallah, Israa H Al-Ani

|Nov 24, 2023
Overview of Availability, Cost, and Affordability of Antibiotics for Adults in Jordan: An AWaRe Classification Perspective.

Feras Darwish Elhajji, Sahar Abuhasheesh, Ahmed Al Rusasi

|Jun 28, 2023
An Evaluation of the Impact of Increasing the Awareness of the WHO Access, Watch, and Reserve (AWaRe) Antibiotics Classification on Knowledge, Attitudes, and Hospital Antibiotic Prescribing Practices.

Salam Abu-Ajaleh, Feras Darwish Elhajji, Shatha Al-Bsoul

Pageof 2

Frequent Collaborators

3 joint publications

Iman A Basheti

2 joint publications

Muna Barakat

2 joint publications

Rana K Abu-Farha

2 joint publications

Samar Thiab